• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Can Aspirin Decrease Risk of Placental Abruption and Antepartum Hemorrhage?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Use of low-dose aspirin early in pregnancy is associated with decreased risk of preeclampsia
  • Abruption and antepartum hemorrhage may also be related to abnormal placentation, similar to preclampsia
  • Roberge et al. (AJOG, 2017) assessed the effect of aspirin on the risk of placental abruption or antepartum hemorrhage, including the effect of gestational age at onset of therapy and dose

METHODS:

  • A systematic review and meta-analysis
  • Researchers analyzed randomized controlled trials evaluating the prophylactic effect of aspirin during pregnancy
  • Relative risk (RR) of placental abruption or antepartum hemorrhage with their 95% confidence intervals (95% CI) were calculated
  • Analyses were stratified according to
    • Daily dose of aspirin (<100 and ≥100 mg)
    • Gestational age of the onset of therapy (≤16 and >16 weeks)

RESULTS:

  • 20 studies met inclusion criteria, totaling 12,585 participants
  • Aspirin at a dose of <100 mg per day did not alter risk of placental abruption or antepartum hemorrhage
    • Initiation at ≤16 weeks: RR 1.11, 95% CI 0.52 to 2.36
    • Initiation at >16 weeks: RR 1.32, 95% CI 0.73 to 2.39
  • Aspirin at a dose of ≥100 mg per day did not alter risk of placental abruption or antepartum hemorrhage
    • Initiation at ≤16 weeks: RR 0.62, 95% CI 0.31 to 1.26
      • Non-significant decreased risk
    • Initiation at >16 weeks: RR 2.08 95% CI 0.86 to 5.06
      • Non-significant increase risk
    • There was a significant difference when comparing these two subgroups (p=0.04)

CONCLUSION:

  • The researchers note potential limitations, including lack of power, to assess subgroups and dose/timing of therapy
  • In the ASPRE trail, prevention of preterm preeclampsia was dependent on compliance and this factor could not be assessed in the present meta-analysis
  • A daily dose of aspirin of greater than 100 mg, initiated at less than 16 weeks of gestation may decrease risk of placental abruption or antepartum hemorrhage
  • Based on previous studies and this current meta-analysis, initiating aspirin after 16 weeks will not only have no impact on preeclampsia but may increase risk of abruption or antepartum hemorrhage

Learn More – Primary Sources:

Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site